TARGA RESOURCES CORP. (TRGP) valuation

Share price $250.73 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted
25.61×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
305.44×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
0.33%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
14.05×
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
3.25×
P/S history →

Price-to-Book

P/B · Latest filing
17.16×
P/B history →

Earning Power Value & reverse-DCF

Not investment advice. Both models below are mechanical algorithms — they don't account for any business-, industry-, or situation-specific context (management changes, regulatory shifts, segment mix, accounting one-offs beyond what XBRL tagging captures, etc.). Neither number is a forecast, a price target, or a suggestion to buy or sell any stock. They are starting points for further analysis, not conclusions.
A note on share counts — three different denominators in play
XBRL exposes three different share figures, and each is the right denominator for a different question:
  • Weighted-average diluted — the filed P/E denominator (NetIncome ÷ this = diluted EPS). Used on the P/E card above because EPS is pulled directly from the EarningsPerShareDiluted XBRL tag and is locked to that share count.
  • Point-in-time CSO (latest CommonStockSharesOutstanding) — matches a point-in-time price for market-cap-based multiples (P/S, P/B, EV/EBITDA, P/FCF, FCF Yield) and the WACC equity weight. Cards labelled "shares outstanding" use this.
  • TSM-scaled diluted — point-in-time CSO scaled by the latest filer-disclosed (WeightedAverageDiluted ÷ WeightedAverageBasic) ratio. Estimates today's fully-diluted share count and is the denominator for the EPV per share and the reverse-DCF equity bridge below.
The three counts drift apart for high-buyback filers; the methodology diluted-shares note walks through which one fits which context and why.

Earning Power Value

Bruce Greenwald's no-growth fair-value floor: capitalise after-tax operating earnings (NOPAT) at the cost of capital (WACC), then bridge to equity (+ excess cash, − total debt, − minority interest). Assumes today's earnings approximate steady-state earnings power and ignores any growth premium. See the EPV methodology for assumptions and caveats.

EPV per share
-$63.62
vs share price $250.73
−125.4%
Trimmed FY-history median margin
3.99%
× Revenue (3-yr FY median)
$14.14B
= Normalized EBIT
$564.2M
× (1 − tax)
0.7900
= NOPAT
$445.7M
÷ WACC
7.55%
= Enterprise EPV
$5.91B
+ Excess cash
$0
− Total debt
$19.48B
− Minority interest
$132.5M
= Equity EPV
-$13.70B
÷ Diluted shares
215.4M

Adjusted variant only: growth CapEx ($1.87B) currently exceeds Normalized NOPAT ($445.7M), so Earnings Power under the "less growth CapEx" framing is negative and the Adjusted EPV is undefined. The Normalized variant (-$63.62 per share) stays usable as the no-growth floor.


EPV full calculation trail Click to expand — every number above derived step by step.

1 · Starting EBIT (TTM)

GAAP operating income from the trailing-twelve-month window ending 2026-03-31 (10-Q anchor — values reconstructed from quarterly facts). Concept: us-gaap: OperatingIncomeLoss


Method: Sum of the four most recent per-quarter values
  Q1 FY26 (2026-03-31): $846.9M
  Q4 FY25 (2025-12-31): $917.4M
  Q3 FY25 (2025-09-30): $836.9M
  Q2 FY25 (2025-06-30): $1.03B
= TTM EBIT = $3.63B
                  

2 · Tax rate derivation

Source: 3-year median of EffectiveTaxRate. See the tax-rate methodology for the full precedence ladder (3-yr median → 2-yr mean → latest FY → REIT-zero → US-statutory default).

Tax rate = 21.0%
                

3 · Normalized NOPAT

Greenwald's textbook EPV normalises both inputs so a single cyclical or one-time-charge year doesn't whipsaw the floor. Margin anchor: when the filer has at least 8 years of FY EBIT-margin history, the 10-90% trimmed median of every FY observation is preferred — it drops the top and bottom decile so a single boom (COVID supply shock, regulatory one-off) or bust year doesn't anchor the floor. Filers with thinner history fall back to the 3-yr FY mean. Revenue follows a backward-looking ladder: 3-yr FY median → 2-yr FY mean → 1-yr FY → TTM fallback. Analyst forecasts are intentionally excluded — the reverse-DCF below is where forward numbers live, except on filers where the TTM EBIT window carried a material whole-segment disposition gain (the FY revenue base then pre-dates the divestiture and overstates the go-forward business — analyst forward FY consensus is preferred, with TTM as a last fallback). The symmetric case fires for partial-period acquisitions: when an FY in the sampled window carries a filer-disclosed pro-forma revenue tag (BusinessAcquisitionsProFormaRevenue) materially higher than reported, the pro-forma value substitutes into the median/mean so the anchor reflects full-period ownership of the acquired entity. See the EPV methodology for the full recipe.


Trimmed FY-history median EBIT margin = 3.99%  (8 of 10 FY observations after 10-90% trim; raw 3-yr mean 19.35%, 3-yr range [19.07%, 19.56%])
TTM EBIT margin      = 21.95%

3-yr FY revenue history:
  FY2025 = $17.03B
  FY2024 = $14.14B   ← median
  FY2023 = $13.52B
Revenue (3-yr FY median) = $14.14B (FY2024)

Normalized EBIT = trimmed FY-history p50 margin × normalisation revenue
                = 3.99% × $14.14B
                = $564.2M

NOPAT = Normalized EBIT × (1 − tax rate)
      = $564.2M × 0.7900
      = $445.7M
                        

4 · Growth CapEx (capex-adjusted variant)

Greenwald's maintenance-CapEx ≈ D&A heuristic. Floored at zero so a filer with CapEx < D&A doesn't get a "negative growth CapEx" bonus added back to NOPAT — that excess D&A is already-paid wear, not earnings. See the EPV methodology .


TTM CapEx — Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  FY FY25 (2025-12-31): +$3.33B
  Q1 FY26 (2026-03-31) YTD: +$899.5M
  Q1 FY25 (2025-03-31) YTD: −$792.2M
= $3.44B
                      

TTM D&A — Sum of the four most recent per-quarter values
  Q1 FY26 (2026-03-31): $426.0M
  Q4 FY25 (2025-12-31): $390.5M
  Q3 FY25 (2025-09-30): $383.5M
  Q2 FY25 (2025-06-30): $373.7M
= $1.57B
                      

TTM SBC — Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  FY FY25 (2025-12-31): +$69.5M
  Q1 FY26 (2026-03-31) YTD: +$23.2M
  Q1 FY25 (2025-03-31) YTD: −$17.6M
= $75.1M
                      
Growth CapEx = max(0, TTM CapEx − TTM D&A)
             = max(0, $3.44B − $1.57B)
             = $1.87B

Adjusted NOPAT = Normalized NOPAT − Growth CapEx
              = $445.7M − $1.87B
              = -$1.42B
                    

5 · Capitalisation rate (WACC)

Same WACC the reverse-DCF below uses — capital-asset pricing model for cost of equity, synthetic-rating credit spread for cost of debt, market weights from the equity bridge inputs. See the WACC methodology and the full WACC trail under section 4 of the reverse-DCF below. β is floored at 1.00 for the cost-of-equity step because empirically the security market line is flatter than CAPM predicts — see methodology.

Cost of equity = Rf + β × ERP
               = 4.3% + 1.00 × 4.5%   (β floored from raw 0.73 to 1.00)
               = 8.8%
Cost of debt   = 4.1% (after-tax, cash-flow walkback: TTM InterestPaidNet ÷ avg debt)
Weights        = E/V 73.4%, D/V 26.6%
WACC           = 7.5%
Without β floor = 6.7%   (β = raw 0.73; cost of equity = 7.6%; +87 bps vs headline — what unfloored CAPM would print)
                    

6 · Enterprise EPV

Enterprise EPV (normalized) = NOPAT ÷ WACC
                            = $445.7M ÷ 7.5%
                            = $5.91B

Enterprise EPV (adjusted)   = (NOPAT − Growth CapEx) ÷ WACC
                            = -$1.42B ÷ 7.5%
                            = —
                

7 · Equity bridge

Same balance-sheet adjustments as the reverse-DCF: add the excess (non-operating) cash an acquirer would pocket at close, subtract the debt that has senior claim on enterprise value, and subtract the noncontrolling interest in consolidated subsidiaries that doesn't accrue to common shareholders. See the balance-sheet aggregates methodology for the exact concept chains.

Enterprise EPV   = $5.91B
+ Excess cash    = $0   (after 2%-TTM-revenue operating-cash floor)
− Total debt     = $19.48B
− NCI            = $132.5M   (book value of MinorityInterest $132.5M)
= Equity EPV     = -$13.70B

Adjusted Equity EPV = — + $0 − $19.48B − $132.5M
                    = —
                

8 · Per share & vs market price

Diluted shares         = 215.4M
EPV / share (normalized) = -13.70B ÷ 215.4M shares
                       = -$63.62
EPV / share (adj.)     = —

Market price           = $250.73
Premium vs price       = (EPV/share − market) ÷ market
                       = −125.4%   (normalized), —   (adjusted)
                

Open this EPV in the calculator → Open EPV with 3-yr mean CapEx →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Expectations investing: what does the price imply?

Path stretch: 10 of 10 years above filer max-ever margin (19.6%)
Alternative framing — margin held flat. If margin stayed at TTM 21.9% across the full 10-year horizon (same growth path, same reinvestment policy), fair value would be $192.78 per share (-23.1% vs the $250.73 market price). The gap of -$57.95 per share is the dollar magnitude of the implied margin compression the price-solved scenario above attributes to the margin axis — the second solver knob the model can't turn while reinvestment is held by the s2c ladder.

Rappaport-style reverse-DCF. We start from the current market price ($250.73 × 215.4M shares = $54.01B market cap, $73.63B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 21.8%
    Scenario holds the analyst consensus (absolute forecast, TTM-anchored) of 21.8%.
  • Target EBIT margin (Y10): 25.9%
    Scenario lands above the 3-yr max of 19.6% (starting 21.9%, ending 25.9%).
  • High-growth plateau: 3 years
    Tier default for Y2 at 12.4%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
+6%
Y4–10
+17%
Terminal
+77%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.


Facts · TTM as of 2026-03-31 (Q12026)

Share price
$250.73
Diluted shares
215.4M
Total debt
$19.48B
Cash & equivalents
$100.1M
Noncontrolling interest
$132.5M
Revenue
$16.56B
EBIT (GAAP)
$3.63B
EBIT margin (GAAP)
21.9%
Operating cash flow
$3.70B
CapEx
$3.44B
Observed YoY growth
1.1%
Analyst current-FY growth
18.5%
Analyst next-FY growth
12.4%
3-year revenue CAGR
-5.8%

Assumptions

Initial revenue growth
21.8%
Year-2 growth
12.4%
Starting EBIT margin
21.9%
Tax rate
19.8% → 21.0%
WACC
7.5%
Starting ROIC
12.1%

Constants

Horizon
10 years
Terminal growth
2.5%
Terminal ROIC
7.5%
Discounting
Mid-year

See the discounting convention, plateau tier rules, and the terminal ROIC fade on the methodology page.


Year-by-year reconciliation

Not a forecast. These are the year-by-year revenue, margin, and cash-flow figures the reverse-DCF solver had to assume for its present value to land on today's enterprise value — the operating path the market price is pricing in, not a view of what the company will deliver.

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $20.17B 21.8% $4.51B 22.3% $3.61B 11.6% $2.27B $1.33B 0.964 $1.29B
2 $22.68B 12.4% $5.16B 22.7% $4.12B 11.2% $2.56B $1.57B 0.897 $1.40B
3 $25.49B 12.4% $5.90B 23.1% $4.71B 10.7% $2.87B $1.84B 0.834 $1.53B
4 $28.30B 11.0% $6.66B 23.5% $5.31B 10.3% $3.19B $2.12B 0.775 $1.64B
5 $31.01B 9.6% $7.43B 23.9% $5.91B 9.8% $3.50B $2.41B 0.721 $1.74B
6 $33.54B 8.2% $8.17B 24.3% $6.49B 9.4% $3.78B $2.71B 0.670 $1.81B
7 $35.80B 6.8% $8.86B 24.7% $7.03B 8.9% $4.04B $2.99B 0.623 $1.87B
8 $37.71B 5.3% $9.48B 25.1% $7.51B 8.5% $4.25B $3.26B 0.579 $1.89B
9 $39.19B 3.9% $10.01B 25.5% $7.92B 8.0% $4.42B $3.50B 0.539 $1.89B
10 $40.17B 2.5% $10.42B 25.9% $8.23B 7.5% $4.53B $3.71B 0.501 $1.86B
Sum of PV of FCF (years 1-10) $16.92B

Terminal value

NOPATN+1
$8.44B
ReinvestmentN+1
$2.73B
FCFN+1
$5.71B
Terminal value (undiscounted)
$113.18B
PV of terminal value
$56.71B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $5.71B ÷ (7.5% − 2.5%).

Equity bridge

PV of operating FCF $16.92B
+ PV of terminal value $56.71B
= Enterprise value $73.63B
− Total debt $19.48B
+ Excess cash $0
total $100.1M − operating $331.2M (2% × TTM revenue)
− Noncontrolling interest $132.5M
= Equity value $54.01B
÷ Diluted shares 215.4M
= DCF PV / share $250.73
Market price $250.73
Reconciliation delta −0.0% (≈ 0 by construction)

Full calculation trail Click to expand — every number on this page derived step by step.

0 · TTM reconstruction (anchor: Q12026, 2026-03-31)

The latest filing is a 10-Q, so "base year" revenue / EBIT / OCF / CapEx are reconstructed as trailing-twelve-month values. Per-quarter facts (typical for income-statement items) get summed across four quarters; YTD-cumulative facts (typical for cash-flow items) use prior FY + YTDnow − YTDprior year same quarter.

Revenue
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $4.09B
  • Q4 FY25 (2025-12-31): $4.06B
  • Q3 FY25 (2025-09-30): $4.15B
  • Q2 FY25 (2025-06-30): $4.26B
  • = $16.56B
EBIT
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $846.9M
  • Q4 FY25 (2025-12-31): $917.4M
  • Q3 FY25 (2025-09-30): $836.9M
  • Q2 FY25 (2025-06-30): $1.03B
  • = $3.63B
OCF
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$3.92B
  • Q1 FY26 (2026-03-31) YTD: +$739.5M
  • Q1 FY25 (2025-03-31) YTD: −$954.4M
  • = $3.70B
CapEx
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$3.33B
  • Q1 FY26 (2026-03-31) YTD: +$899.5M
  • Q1 FY25 (2025-03-31) YTD: −$792.2M
  • = $3.44B
Stock-based compensation
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$69.5M
  • Q1 FY26 (2026-03-31) YTD: +$23.2M
  • Q1 FY25 (2025-03-31) YTD: −$17.6M
  • = $75.1M
Prior-year TTM revenue (growth-calc baseline)
Sum of the four most recent per-quarter values
  • Q1 FY25 (2025-03-31): $4.56B
  • Q4 FY24 (2024-12-31): $4.41B
  • Q3 FY24 (2024-09-30): $3.85B
  • Q2 FY24 (2024-06-30): $3.56B
  • = $16.38B

1 · Enterprise-value target (what the DCF must match)

Diluted shares = point-in-time basic × 1.0033× (filer's TSM dilution multiplier from WeightedAverageNumberOfDilutedSharesOutstanding ÷ WeightedAverageNumberOfSharesOutstandingBasic , period ending 2026-03-31 ). See the diluted-shares methodology.

Total debt $19.48B bundles:
  • Long-term debt $19.13B LongTermDebt
  • Finance lease liability $346.5M FinanceLeaseLiabilityCurrent + FinanceLeaseLiabilityNoncurrent
Operating- and finance-lease liabilities and any tagged underfunded pension obligation are folded into total debt as Damodaran-style debt-equivalents on top of the financial-debt concepts; see the total-debt methodology.

Noncontrolling interest = book NCI on the consolidated BS ( MinorityInterest $132.5M ). Subtracted from the equity bridge so per-share fair value reflects the common-shareholder claim only. See the NCI methodology.

Cash is split into the operating floor an operating business needs (2% of revenue, Damodaran heuristic) and the distributable surplus that flows to equity holders. Only excess cash is netted against debt because the DCF values the operating business, and the operating cash stays inside it. Banks, insurers, and REITs are exempt — their cash backs deposits / regulatory reserves / investment portfolios rather than working capital. See the methodology.

Market cap     = price × diluted shares
               = $250.73 × 215.4M
               = $54.01B

Total cash     = $100.1M
Operating cash = 2% × revenue = $331.2M
Excess cash    = max(0, total − operating) = $0

EV target      = market cap + total debt + NCI − excess cash
               = $54.01B + $19.48B + $132.5M − $0
               = $73.63B
            

2 · Starting NOPAT (base year 0)

Tax rate source: 3-year median of EffectiveTaxRate. See the tax-rate methodology for the precedence ladder.

Tax rate fades from 19.8% at year 0 to 21.0% at year 10 (US federal statutory floor). The current effective rate is the most honest reading of this filer's recent economics, but holding it as the perpetuity rate would compound a one-off NOL benefit / R&D credit / foreign-mix tilt across the whole horizon. WACC's after-tax cost of debt uses the terminal rate so the discount rate is consistent with the long-run cash flows it discounts.

GAAP EBIT          = $3.63B   (21.9% of revenue)
× (1 − tax rate)  = × (1 − 19.8%) = × 0.8016
= NOPAT₀            = $2.91B
            

3 · Invested capital & starting ROIC

Net deferred-tax position (-$1.48B net DTL) stripped from IC. DTAs (NOL / credit carryforwards, post valuation allowance) and DTLs (timing differences from accelerated depreciation) are tax-accounting artifacts, not capital deployed in operations — equity-based IC inadvertently absorbs them via E = Assets − Liabilities, so we back them out so ROIC reflects operating returns on operating capital.

Invested capital = total debt + book equity − excess cash − net deferred tax (−DTL)
                 = $19.48B + $3.14B − $0 − -$1.48B
                 = $24.09B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $2.91B / $24.09B
                 = 12.1%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · WACC derivation

Cost of equity from CAPM , after-tax cost of debt measured directly as TTM cash interest paid divided by average total debt (the cash-flow walkback path — bypasses the synthetic coverage table because debt is material and the cash flow statement carries a usable InterestPaidNet figure) , weighted by market values of equity and debt. Inputs: Rf is FRED DGS10's 90-day mean (latest 2026-05-29); β is the 5-yr weekly regression vs VOO, floored at 1.00 for the cost-of-equity step (the empirical security market line is much flatter than CAPM predicts — Frazzini-Pedersen 2014, "Betting Against Beta" — so unfloored CAPM systematically under-estimates required return for low-β filers); ERP is the latest Damodaran US total ERP (2026-01-01). See cost-of-debt methodology for why the walkback path is the more honest input for the leveraged-asset cohort (cable, telecom, auto, utility-adjacent industrials).

Cost of equity        = Rf + β × ERP
                      = 4.3% + 1.00 × 4.5%   (β floored from raw 0.73 to 1.00)
                      = 8.8%

Cost of debt (pretax) = TTM cash interest paid ÷ avg total debt
                      = $836.4M ÷ $16.24B   (avg of 2025-12-31: $17.90B and 2024-12-31: $14.59B)
                      = 5.1%   (cash-flow walkback; bypasses synthetic coverage table)
× (1 − tax rate)      = × (1 − 19.8%)
= Cost of debt (a/t)  = 4.1%

Weights               E/V = 73.4%, D/V = 26.6%

WACC (raw)            = E/V × cost_e + D/V × cost_d_after_tax
                      = 73.4% × 8.8% + 26.6% × 4.1%
                      = 7.5%

Sensitivity: without β floor
WACC                  = 73.4% × 7.6% + 26.6% × 4.1%
                      = 6.7%   (β = raw 0.73; +87 bps vs headline — what unfloored CAPM would print)
                

5 · Growth path construction


Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = 21.8%, Y2 = 12.4%

Detailed derivation:
  Current-FY analyst avg revenue forecast = $20.17B   (FY-over-FY vs FY2025 actual = 18.5%)
  Next-FY analyst avg revenue forecast    = $22.68B   (FY-over-FY vs current-FY forecast = 12.4%)
  Base revenue (TTM) = $16.56B
  Latest completed FY revenue (FY2025) = $17.03B   (denominator for the FY-over-FY check above)

  Y1 = current-FY forecast / TTM base revenue − 1
     = $20.17B / $16.56B − 1
     = 21.8%

  Y2 = next-FY forecast / current-FY forecast − 1
     = $22.68B / $20.17B − 1
     = 12.4%

  Note: the absolute analyst forecast is re-anchored
  against TTM (rather than the FY-over-FY consensus
  rate above) because the TTM base spans the current
  FY only partway. Re-anchoring keeps the growth rate
  consistent with the projection's starting revenue
  level.
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 12.4% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = 21.8%
Effective Y2 growth after solver bumps = 12.4%
Growth by year:
  Y1 = 21.8%
  Y2 = 12.4%
  Y3 = 12.4%
  Y4 = 11.0%
  Y5 = 9.6%
  Y6 = 8.2%
  Y7 = 6.8%
  Y8 = 5.3%
  Y9 = 3.9%
  Y10 = 2.5%
                

6 · Margin path construction

Starting margin (Y0) = 21.9%   (source: TTM EBIT margin (GAAP) — within 4pp of 3-yr mean)
Target margin (Y10)  = 25.9%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 22.3%
  Y2 = 22.7%
  Y3 = 23.1%
  Y4 = 23.5%
  Y5 = 23.9%
  Y6 = 24.3%
  Y7 = 24.7%
  Y8 = 25.1%
  Y9 = 25.5%
  Y10 = 25.9%

Filer-history margin distribution (10 FY, trimmed-10-90):
  p25 = 2.1%, p50 = 4.0%, p75 = 11.3%
  raw min = -19.0%, raw max = 19.6%
Path-stretch sub-counts:
  10 of 10 years above filer p75 (11.3%)
  10 of 10 years above filer max-ever (19.6%)
  Terminal/start ratio = 118%
Binding trigger = unprecedented-margin (drives the page badge)
            

7 · ROIC path construction

The capex heuristic compares latest-period CapEx ($3.44B) against the Normalized CapEx (3-yr mean) of $2.89B — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 1.19× the 3-yr mean of $2.89B — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 12.1%; ROIC_terminal = 7.5%

ROIC by year:
  Y1 = 11.6%
  Y2 = 11.2%
  Y3 = 10.7%
  Y4 = 10.3%
  Y5 = 9.8%
  Y6 = 9.4%
  Y7 = 8.9%
  Y8 = 8.5%
  Y9 = 8.0%
  Y10 = 7.5%
            

7a · Reinvestment formula

The Damodaran growth-firm closure Reinvestment_t = ΔRevenue_t ÷ salesToCapital collapses to noise whenever EITHER the 3-year revenue change OR the 3-year net reinvestment is small relative to the revenue base. The model picks the most-honest formula via a 3-tier ladder: tier-1 standard sales-to-capital fires only when both signals carry magnitude AND the resulting ratio sits inside the typical 0.5–8 band; tier-2 substitutes a TTM (CapEx − D&A) ÷ Revenue ratio applied to each projection year's revenue (not its delta); tier-3 falls through to the ΔNOPAT ÷ ROIC closure when neither signal is usable.

Inputs:
  ΔRev_3y                          = -$3.26B
  netReinvest_3y (CapEx − D&A)     = $4.42B
  avgRevenue_3y                    = $18.19B
  TTM CapEx − D&A                  = $1.87B
  TTM Revenue                      = $16.56B

Tier-1 gates (all three must clear):
  |ΔRev_3y| / avgRev_3y > 1.0%     17.92%         ✓ pass
  netReinv_3y / avgRev_3y > 1.5%   24.28%         ✓ pass
  0.5 ≤ s2c candidate ≤ 8          n/a            ✗ fail

Tier-2 fires (gate failed: no-candidate). Substituting CapEx-of-revenue heuristic.
  capexOfRevenueRatio (raw)        = 11.27%
  capexOfRevenueRatio (used)       = 11.27%
  Reinvestment_t = Revenue_t × 11.27%
            

8 · Solver iterations

Each row is one configuration in the solver ladder; the "Solved margin" column is the result of bisecting the EBIT margin (up to 80 inner iterations) to match the EV target for that row's plateau / Y1 bump / phase. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible row is the one the page uses. If no combination reconciles, the page shows the row whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 25.9% $73.63B −0.0% yes ✓

9 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $8.23B × (1 + 2.5%)
                    = $8.44B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $205.8M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $205.8M / 7.5%
                    = $2.73B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $8.44B − $2.73B
                    = $5.71B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $5.71B / (7.5% − 2.5%)
                    = $113.18B

PV(TV)              = TV / (1 + WACC)^(10 − 0.5)
                    = $113.18B / 1.996
                    = $56.71B

10 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $16.92B
+ PV(TV)          = $56.71B
= Enterprise value = $73.63B   (≈ EV target $73.63B by construction)
− Total debt      = $19.48B
+ Excess cash     = $0   (total $100.1M − operating $331.2M)
− NCI             = $132.5M
= Equity value    = $54.01B
÷ Diluted shares  = 215.4M
= DCF PV / share  = $250.73

Market price      = $250.73
Reconciliation Δ  = −0.0%   (≈ 0 by construction — the solver anchored on this price)
                

Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the Financials methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for TRGP (CIK 0001389170); analyst growth forecasts come from analyst consensus. Filing-anchored figures are rendered server-side at the split-adjusted close on the latest reported period-end — so every ratio reconciles to the same filing as every other figure on this page — and the share price, six ratio cards, EPV gap, and reverse-DCF outputs above re-anchor on the most recent daily close in the browser when JavaScript is enabled. The "Full calculation trail" sections stay anchored to the period-end close so the line-by-line arithmetic still reconciles. Per-share denominators are split-adjusted to today's share count.

Related tickers

UPWK

UPWORK INC.

DAKT

Daktronics, Inc.

MRP

Millrose Properties, Inc.